Surgery Partners, Inc. · NASDAQ:SGRY
Surgery Partners — Debt Investor Presentation (March 2016)
8 slides from Surgery Partners's debt investor presentation, Mar 14, 2016
Slide 1: Lender Presentation March 2016
Lender Presentation March 2016 Exhibit 99.1
Slide 2: Executive Summary
2 Executive Summary Surgery Partners, Inc. (“Surgery Partners” or the “Company”) is a leading surgical services company with a differentiated outpatient care delivery model National platform of 101 surgical facilities comprised of 96 ambulatory surgery centers (“ASCs”) and 5 surgical hospitals acros
Slide 3: Sources and Uses and Pro Forma Capitalization
3 Sources and Uses and Pro Forma Capitalization Sources and Uses Pro Forma Capitalization 12/31/15 Represents contingent consideration payable in equal installments over 3 years related to an acquisition in connection with the Transaction, subject to continued employment of the sellers. Pro forma fo
Slide 4: Summary of Terms
Summary of Terms Borrower Surgery Center Holdings, Inc. Facility $80 million Incremental First Lien Term Loan Guarantors Same as existing First Lien Term Loan Security Same as existing First Lien Term Loan Maturity November 3, 2020 (Same as existing First Lien Term Loan) Pricing L + 425 (Same as exi
Slide 5: Acquisitions Under Signed LOI
Acquisitions Under Signed LOI As part of the Transaction, Surgery Partners intends to fund the acquisition of 1 ASC (with a physician practice, lab and pharmacy) and 1 physician practice Acquisitions are under signed LOI for an aggregate purchase price of $91.1million Incremental EBITDA contribution
Slide 6: Anticipated Transaction Timeline
Anticipated Transaction Timeline Date Event March 14, 2016 Announce Transaction Distribute Loan Amendment Documentation Signature Pages Due for Loan Amendment Documentation Close and Fund March 18, 2016 March 31, 2016 Denotes holiday March 2016 S M T W T F S 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Slide 7: Appendix
Appendix sik SURGERY PARTNERS
Slide 8: Credit Agreement EBITDA Reconciliation
Credit Agreement EBITDA Reco nciliation Includes cost savings from corporate overhead reduction, office consolidation, optimized supply chain and revenue synergies from diagnostic and anesthesia services penetration and greater leverage in managed care contract negotiations due to significant enhanc
Surgery Partners — Debt Investor Presentation (March 2016) on 6ix